Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Equivalence of CinnoRA vs Humira in Healthy Subjects
NCT03273192Phase 1Completed
- Sponsor
- CinnaGen
- Start
- Oct 2016
- Primary completion
- Aug 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of CinnoRA in rheumatoid arthritis (RA) (2 arms), sponsored by CinnaGen. Primary endpoints: Area under the concentration-time curve from time zero to infinity at 71 days and Maximum serum concentration at 71 days. Started Oct 2016; status: completed.
02
Drugs
CinnoRA
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03273192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03273192.